Albert Fink in Springfield, Pennsylvania

Medical School: Sorry, his university is not listed
Graduation Year: 1981
The Primary Medical Specialty for Albert Fink is listed as: Internal Medicine
Approximate Years of Experience: 43
PAC (PECOS ID)#: 8224173083
NPI #: 1053347740
NPI Created On: 06/24/2006
NPI Last Updated Listed as: 06/26/2015
Primary Taxonomy Code: 207R00000X
License Number:
MD027892E
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• AmeriHealth New Jersey
• Blue Cross Blue Shield
• Highmark Health Insurance Company
• AmeriHealth HMO, Inc.
• Highmark Inc.
• Pennsylvania Health & Wellness, Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Spanish, English.

Services and Procedures include:

1. Aspiration and/or injection of large joint or joint capsule
2. Insertion of needle into vein for collection of blood sample
3. Vaccine for influenza for injection into muscle
4. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
5. Routine ekg using at least 12 leads including interpretation and report
6. New patient office or other outpatient visit, typically 45 minutes
7. Established patient office or other outpatient visit, typically 15 minutes
8. Established patient office or other outpatient, visit typically 25 minutes
9. Established patient office or other outpatient, visit typically 40 minutes
10. Physician telephone patient service, 11-20 minutes of medical discussion
11. Physician telephone patient service, 21-30 minutes of medical discussion
12. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
13. Administration of influenza virus vaccine
14. Administration of pneumococcal vaccine
15. Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem
16. Injection, denosumab, 1 mg
17. Injection, triamcinolone acetonide, not otherwise specified, 10 mg